These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29769910)

  • 1. Analyzing and strengthening the vaccine safety program in Manitoba.
    Montalban JM; Ogbuneke C; Hilderman T
    Can Commun Dis Rep; 2014 Dec; 40(Suppl 3):31-36. PubMed ID: 29769910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family Medicine Program in Iran: SWOT Analysis and TOWS Matrix Model.
    Dargahi H; Darrudi A; Zalvand R
    Iran J Public Health; 2019 Jun; 48(6):1140-1148. PubMed ID: 31341857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).
    von Kodolitsch Y; Bernhardt AM; Robinson PN; Kölbel T; Reichenspurner H; Debus S; Detter C
    Aorta (Stamford); 2015 Jun; 3(3):98-107. PubMed ID: 27069939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease-2019 risk management using strengths, weaknesses, opportunities, threats analysis approach in the health system: A qualitative multimethod study.
    Bazyar J; Alimoradi S; Seydi M; Pourvakhshoori N; Sadeghifar J
    J Educ Health Promot; 2021; 10():453. PubMed ID: 35233400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE STRENGTHS, WEAKNESSES, OPPORTUNITIES, AND THREATS (SWOTs) ANALYSES OF THE EBOLA VIRUS - PAPER RETRACTED.
    Babalola MO
    Afr J Infect Dis; 2016; 10(2):69-88. PubMed ID: 28480441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
    Ramezanpour B; Pronker ES; Kreijtz JH; Osterhaus AD; Claassen E
    Vaccine; 2015 Aug; 33(35):4349-58. PubMed ID: 26048779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property management at the National Animal Science Research Institute in India: A case study.
    Chandrasekharan CC; Jiji RS
    Vet World; 2019 Jul; 12(7):1070-1077. PubMed ID: 31528035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.
    Sadler SJ; Torio EF; Golby AJ
    Cancer; 2023 Mar; 129(5):671-684. PubMed ID: 36597652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A SWOT (strengths, weaknesses, opportunities, threats) analysis of the current immunization program in Zhejiang Province].
    He HQ; Ling LY; Xu XQ
    Zhongguo Yi Miao He Mian Yi; 2009 Feb; 15(1):65-7. PubMed ID: 20077680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rollout of COVID-19 Vaccination in India: A SWOT Analysis.
    Sharma P; Pardeshi G
    Disaster Med Public Health Prep; 2021 Apr; ():1-4. PubMed ID: 33820581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis of Hemodialysis Electronic Health Record Implementation.
    Bennis B; El Bardai G; Chouhani BA; Kabbali N; Sqalli T
    Cureus; 2024 Feb; 16(2):e54675. PubMed ID: 38523930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia.
    Littlejohn ES; Clothier HJ; Perrett KP; Danchin M
    Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWOT analysis: strengths, weaknesses, opportunities and threats of the Israeli Smallpox Revaccination Program.
    Huerta M; Balicer RD; Leventhal A
    Isr Med Assoc J; 2003 Jan; 5(1):42-6. PubMed ID: 12592958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
    Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
    Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic analysis of influenza vaccine shortage policies.
    Uscher-Pines L; Barnett DJ; Sapsin JW; Bishai DM; Balicer RD
    Public Health; 2008 Feb; 122(2):183-91. PubMed ID: 17825858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
    Nguyen M; Ball R; Midthun K; Lieu TA
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.